Predicate |
Object |
contentType |
Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review |
endingPage |
16 |
issn |
0014-5793 1873-3468 |
issueIdentifier |
1 |
pageRange |
3-16 |
publicationName |
FEBS Letters |
startingPage |
3 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_21a30339bae3a924a4fae709a0a2f262 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f7bbc019877f9c0b09ff7c84c52cd262 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0e62bc8833b070438f37a9ac474daf80 |
bibliographicCitation |
Arora GK, Palamiuc L, Emerling BM. Expanding role of PI5P4Ks in cancer: A promising druggable target. FEBS Letters. 2021 Dec 07;596(1):3–16. doi: 10.1002/1873-3468.14237. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2168-4582 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c1aba492321e92ed38f064d4edc5fbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98709690d6cccf656e44dfe156932f39 |
date |
2021-12-07^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1002/1873-3468.14237 https://pubmed.ncbi.nlm.nih.gov/34822164 https://pubmed.ncbi.nlm.nih.gov/PMC9154051 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3696 https://portal.issn.org/resource/ISSN/0014-5793 https://portal.issn.org/resource/ISSN/1873-3468 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Expanding role of PI5P4Ks in cancer: A promising druggable target |
discusses |
http://id.nlm.nih.gov/mesh/M0026976 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0024670 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D017853 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b8f9311b0b0ef56f89dec03fc02e00b |